Akèy › Maladi selil fòs › Distrik Columbia › Washington
Etid klinik pou Maladi selil fòs nan Washington, DC
20 etid pou Maladi selil fòs ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Blood Sampling for Research Related to Sickle Cell Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Ap rekriteFaz 3
- Childrens National Hospital, Washington D.C.
Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
Ap rekriteFaz 1 bonè
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
Ap rekriteFaz 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Ap rekriteFaz 3
- Childrens National Medical Ctr, Washington D.C.
- MedStar Hlth Res Institute, Washington D.C.
Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
SCD Stem Cell Mobilization and Apheresis Using Motixafortide
Ap rekriteFaz 1
- National Heart, Blood and Lung Institute-Cellular and Molecular Therapy Branch, Bethesda · 7 mi lwen
Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
Ap rekriteFaz 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
Ap rekriteFaz 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Ap rekriteEtid obsèvasyon
- Georgetown University, Washington D.C.
- Children's National Hemophilia Center, Washington D.C.
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
Ap rekriteFaz 2
- Center for Cancer and Blood Disorders, Bethesda · 7 mi lwen
Cooperative Assessment of Late Effects for SCD Curative Therapies
Ap rekriteEtid obsèvasyon
- Children's National Medical Center, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
Ap rekriteEtid obsèvasyon
- Children's National Hospital (MRD-HCT), Washington D.C.
Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease
Ap rekriteFaz 2
- Children's National Hospital, Washington D.C.
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
Ap rekriteFaz 2
- Children's National Health System, Washington D.C.
Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
Ap rekriteFaz 2
- Children's National Hospital, Washington D.C.
Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease
Ap rekrite
- Children's National Hospital, Washington D.C.
Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
Ap rekrite
- Children's National Hospital, Washington D.C.
Etid Maladi selil fòs nan lòt vil
- Atlanta, GA22 etid
- Chicago, IL18 etid
- Memphis, TN18 etid
- Philadelphia, PA15 etid
- Birmingham, AL14 etid
- New York City, NY13 etid
- St. Louis, MO12 etid
- Boston, MA10 etid
- Durham, NC10 etid
- Houston, TX10 etid
- Cincinnati, OH10 etid
- Greenville, NC9 etid
Lòt etid nan Washington
- Kansè (tout kalite)58 etid
- Kansè Poumon ki pa ti selil55 etid
- Kansè nan tete46 etid
- Kansè Metastatik43 etid
- Kansè poumon41 etid
- Kansè pwostat38 etid
- Obèsite33 etid
- Kansè kolorektal29 etid
- Maladi kadyovaskilè28 etid
- Kansè vejik26 etid
- Leksemi mieloïd egi24 etid
- Kansè ovè23 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.